These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1223 related articles for article (PubMed ID: 12612581)

  • 1. An essential role for Scurfin in CD4+CD25+ T regulatory cells.
    Khattri R; Cox T; Yasayko SA; Ramsdell F
    Nat Immunol; 2003 Apr; 4(4):337-42. PubMed ID: 12612581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising Foxp3+CD25+CD4+ regulatory T cells.
    Nishimura E; Sakihama T; Setoguchi R; Tanaka K; Sakaguchi S
    Int Immunol; 2004 Aug; 16(8):1189-201. PubMed ID: 15237110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD25(+)CD4(+) regulatory T cells exert in vitro suppressive activity independent of CTLA-4.
    Kataoka H; Takahashi S; Takase K; Yamasaki S; Yokosuka T; Koike T; Saito T
    Int Immunol; 2005 Apr; 17(4):421-7. PubMed ID: 15724061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overlap between molecular markers expressed by naturally occurring CD4+CD25+ regulatory T cells and antigen specific CD4+CD25+ and CD8+CD28- T suppressor cells.
    Scotto L; Naiyer AJ; Galluzzo S; Rossi P; Manavalan JS; Kim-Schulze S; Fang J; Favera RD; Cortesini R; Suciu-Foca N
    Hum Immunol; 2004 Nov; 65(11):1297-306. PubMed ID: 15556680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity.
    Bianchini R; Bistoni O; Alunno A; Petrillo MG; Ronchetti S; Sportoletti P; Bocci EB; Nocentini G; Gerli R; Riccardi C
    Eur J Immunol; 2011 Aug; 41(8):2269-78. PubMed ID: 21557210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.
    Fontenot JD; Gavin MA; Rudensky AY
    Nat Immunol; 2003 Apr; 4(4):330-6. PubMed ID: 12612578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro generation and characterisation of murine CD4+CD25+ regulatory T cells with indirect allospecificity.
    Tsang J; Jiang S; Tanriver Y; Leung E; Lombardi G; Lechler RI
    Int Immunopharmacol; 2006 Dec; 6(13-14):1883-8. PubMed ID: 17161341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4+CD25bright T cells in human intestinal lamina propria as regulatory cells.
    Makita S; Kanai T; Oshima S; Uraushihara K; Totsuka T; Sawada T; Nakamura T; Koganei K; Fukushima T; Watanabe M
    J Immunol; 2004 Sep; 173(5):3119-30. PubMed ID: 15322172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The origin of thymic CD4+CD25+ regulatory T cells and their co-stimulatory requirements are determined after elimination of recirculating peripheral CD4+ cells.
    Zhan Y; Bourges D; Dromey JA; Harrison LC; Lew AM
    Int Immunol; 2007 Apr; 19(4):455-63. PubMed ID: 17314081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [T cell mediated immunoregulation and autoimmune disease].
    Takahashi T; Sakaguchi S
    Tanpakushitsu Kakusan Koso; 2002 Dec; 47(16 Suppl):2331-5. PubMed ID: 12518457
    [No Abstract]   [Full Text] [Related]  

  • 11. Removal of regulatory T cell activity reverses hyporesponsiveness and leads to filarial parasite clearance in vivo.
    Taylor MD; LeGoff L; Harris A; Malone E; Allen JE; Maizels RM
    J Immunol; 2005 Apr; 174(8):4924-33. PubMed ID: 15814720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells.
    Yagi H; Nomura T; Nakamura K; Yamazaki S; Kitawaki T; Hori S; Maeda M; Onodera M; Uchiyama T; Fujii S; Sakaguchi S
    Int Immunol; 2004 Nov; 16(11):1643-56. PubMed ID: 15466453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of antigen-specific regulatory T cells in the liver-draining celiac lymph node following oral antigen administration.
    Hultkrantz S; Ostman S; Telemo E
    Immunology; 2005 Nov; 116(3):362-72. PubMed ID: 16236126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of highly suppressive adaptive CD8(+)CD25(+)FOXP3(+) regulatory T cells by continuous antigen stimulation.
    Mahic M; Henjum K; Yaqub S; Bjørnbeth BA; Torgersen KM; Taskén K; Aandahl EM
    Eur J Immunol; 2008 Mar; 38(3):640-6. PubMed ID: 18266270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of FOXP3+ regulatory T-cells in peripheral blood of patients with NSCLC.
    Li L; Chao QG; Ping LZ; Xue C; Xia ZY; Qian D; Shi-ang H
    Cancer Biother Radiopharm; 2009 Jun; 24(3):357-67. PubMed ID: 19538059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-beta requires CTLA-4 early after T cell activation to induce FoxP3 and generate adaptive CD4+CD25+ regulatory cells.
    Zheng SG; Wang JH; Stohl W; Kim KS; Gray JD; Horwitz DA
    J Immunol; 2006 Mar; 176(6):3321-9. PubMed ID: 16517699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
    Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
    Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NFATc2 and NFATc3 transcription factors play a crucial role in suppression of CD4+ T lymphocytes by CD4+ CD25+ regulatory T cells.
    Bopp T; Palmetshofer A; Serfling E; Heib V; Schmitt S; Richter C; Klein M; Schild H; Schmitt E; Stassen M
    J Exp Med; 2005 Jan; 201(2):181-7. PubMed ID: 15657288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
    Ahn JS; Krishnadas DK; Agrawal B
    Int Immunol; 2007 Mar; 19(3):227-37. PubMed ID: 17289657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.
    Chen W; Jin W; Hardegen N; Lei KJ; Li L; Marinos N; McGrady G; Wahl SM
    J Exp Med; 2003 Dec; 198(12):1875-86. PubMed ID: 14676299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.